
Medrhys Pharma Private Limited
Founded in 2009 and headquartered in Pondicherry, India.
Founded in 2009 and headquartered in Pondicherry, India.
Pondicherry, Pondicherry, India
+91-XXXXXXXXXX
U24239PY2009PTC002263
002263
Private Limited Indian Non-Government Company
13 Feb 2009
30 Sep 2011
31 Mar 2011
Unlisted
Roc Pondicherry
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arumugam Saravanan ![]() | Director | 13-Feb-2009 | Current |
Saravanan Vanaja ![]() | Director | 13-Feb-2009 | Current |
Enhance accessibility to Medrhys Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Medrhys Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Arumugam Saravanan and Saravanan Vanaja are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medrhys Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medrhys Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medrhys Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medrhys Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records.
Medrhys Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Pondicherry.
Arumugam Saravanan was appointed as a Director was appointed as a Director on 13 Feb 2009 & has been associated with this company since 16 years 30 days .
Saravanan Vanaja was appointed as a Director was appointed as a Director on 13 Feb 2009 & has been associated with this company since 16 years 30 days .
Medrhys Pharma Private Limited was registered on 13 Feb 2009 with Roc Pondicherry & aged 16 years 30 days as per MCA records.
Medrhys Pharma Private Limited was incorporated on 13 Feb 2009.
The authorized share capital of Medrhys Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Medrhys Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medrhys Pharma Private Limited is R.S.No.49/1 Thethambakkam Road, Kumarapalayam Valudavur Post Puducherry, Puducherry Pondicherry, India, 605502.
The corporate identification number (CIN) of Medrhys Pharma Private Limited is U24239PY2009PTC002263 and the company number is 002263 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Medrhys Pharma Private Limited was filed with the ROC on 31 Mar 2011.
Search company & director profiles for free and gain access to critical business data.
BR
GC
SV